Flower And Tissue India Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 18-12-2024
- Paid Up Capital ₹ 5.24 Cr
as on 18-12-2024
- Company Age 34 Year, 4 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 1.50 Cr
as on 18-12-2024
- Satisfied Charges ₹ 3.55 Cr
as on 18-12-2024
- Revenue 731.95%
(FY 2017)
- Profit 499.64%
(FY 2017)
- Ebitda 799.12%
(FY 2017)
- Net Worth 77.20%
(FY 2017)
- Total Assets 1460.66%
(FY 2017)
About Flower And Tissue India
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 5.24 Cr.
The company currently has active open charges totaling ₹1.50 Cr. The company has closed loans amounting to ₹3.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vinesh Bhargava, Umesh Bhargava, and Rashmi Bhargava serve as directors at the Company.
- CIN/LLPIN
U15499RJ1990PLC005531
- Company No.
005531
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Aug 1990
- Date of AGM
31 Aug 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Flower And Tissue India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinesh Bhargava  | Director | 07-Aug-1990 | Current |
| Umesh Bhargava | Director | 25-Apr-2011 | Current |
| Rashmi Bhargava | Director | 31-Mar-2003 | Current |
Financial Performance and Corporate Structure Insights of Flower And Tissue India.
Flower And Tissue India Ltd., for the financial year ended 2017, experienced significant growth in revenue, with a 731.95% increase. The company also saw a substantial improvement in profitability, with a 499.64% increase in profit. The company's net worth Soared by an impressive increase of 77.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Flower And Tissue India?
In 2017, Flower And Tissue India had a promoter holding of 3.34% and a public holding of 96.66%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Risk Capital & Technology Finance Corporation Ltd. Creation Date: 22 Sep 2003 | ₹6.00 M | Open |
Risk Capital And Technology Finance Corporation Ltd. Creation Date: 19 Aug 1994 | ₹4.00 M | Open |
Risk Capital & Technology Finance Corporation Ltd. Creation Date: 20 Aug 1993 | ₹2.50 M | Open |
How Many Employees Work at Flower And Tissue India?
Unlock and access historical data on people associated with Flower And Tissue India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Flower And Tissue India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Flower And Tissue India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
